Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System
Conditions: Vaccine Reaction Interventions: Drug: Gardasil; Drug: Gardasil; Drug: Gardasil; Device: PharmaJet Stratis ® Needle-Free Injection System; Device: PharmaJet Tropis® Needle-Free Injection System Sponsors: PharmaJet, Inc.; National Institutes of Health (NIH); National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
Conditions: Adrenal Cortical Carcinoma; Medullary Thyroid Cancer; Thymic Neuroendocrine Carcinoma; Pancreatic Neuroendocrine Tumor Interventions: Biological: individualized mRNA neoantigen vaccine (mRNA-0523-L001) Sponsors: Shanghai Jiao Tong University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity
Conditions: HPV Infection; HPV Vaccine; Cervical Cancer Prevention Interventions: Other: Follow up Sponsors: Fujian Maternity and Child Health Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Conditions: Health Behavior; Colorectal Cancer; Influenza; COVID-19; Vaccine Hesitancy; Vaccine-Preventable Diseases; Healthcare Patient Acceptance Interventions: Behavioral: Financial incentive for colorectal cancer screening; Behavioral: Financial incentive for flu shot; Behavioral: Financial incentive for COVID-19 shot Sponsors: Tulane University; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Conditions: Neuroblastoma; High-risk Neuroblastoma; Metastatic Neuroblastoma Interventions: Biological: OPT-821 (QS-21); Dietary Supplement: oral β-glucan Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Conditions: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; Chronic Myeloid Leukemia, BCR-ABL1 Positive; Hematopoietic and Lymphoid System Neoplasm; Hodgkin Lymphoma; Myelodysplastic Syndrome; Myelofibrosis; Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation; Procedure: Biospecimen Collection; Drug: Granulocyte Colony-Stimulating Factor; Drug: Hematopoietic Cell Transplantation Conditioning Regimen; Biological: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine; Procedure: Pheresis; Drug: Placebo Administration; ...
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL
Conditions: Vulvar HSIL; HPV Interventions: Drug: Gardasil 9 Suspension for Injection; Drug: Placebo Sponsors: Erasmus Medical Center; Dutch Cancer Society Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II
Conditions: CIN3; Cervical Intraepithelial Neoplasia; Cervical Intraepithelial Neoplasia Grade 3; HPV 16 Infection Intervention: Biological: Vvax001 therapeutic cancer vaccine Sponsors: University Medical Center Groningen; Dutch Cancer Society; ViciniVax B.V Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer
Conditions: Pancreatic Ductal Adenocarcinoma; Refractory Non-Small Cell Lung Cancer Interventions: Drug: Daratumumab; Biological: KRAS vaccine; Drug: Nivolumab Sponsors: Georgetown University; Bristol-Myers Squibb; Janssen, LP; Targovax ASA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II
Conditions: CIN3; Cervical Intraepithelial Neoplasia; Cervical Intraepithelial Neoplasia Grade 3; HPV 16 Infection Intervention: Biological: Vvax001 therapeutic cancer vaccine Sponsors: University Medical Center Groningen; Dutch Cancer Society; ViciniVax B.V Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer
Conditions: Pancreatic Ductal Adenocarcinoma; Refractory Non-Small Cell Lung Cancer Interventions: Drug: Daratumumab; Biological: KRAS vaccine; Drug: Nivolumab Sponsors: Georgetown University; Bristol-Myers Squibb; Janssen, LP; Targovax ASA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II
Conditions: CIN3; Cervical Intraepithelial Neoplasia; Cervical Intraepithelial Neoplasia Grade 3; HPV 16 Infection Intervention: Biological: Vvax001 therapeutic cancer vaccine Sponsors: University Medical Center Groningen; Dutch Cancer Society; ViciniVax B.V Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer
Conditions: Pancreatic Ductal Adenocarcinoma; Refractory Non-Small Cell Lung Cancer Interventions: Drug: Daratumumab; Biological: KRAS vaccine; Drug: Nivolumab Sponsors: Georgetown University; Bristol-Myers Squibb; Janssen, LP; Targovax ASA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II
Conditions: CIN3; Cervical Intraepithelial Neoplasia; Cervical Intraepithelial Neoplasia Grade 3; HPV 16 Infection Intervention: Biological: Vvax001 therapeutic cancer vaccine Sponsors: University Medical Center Groningen; Dutch Cancer Society; ViciniVax B.V Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer
Conditions: Pancreatic Ductal Adenocarcinoma; Refractory Non-Small Cell Lung Cancer Interventions: Drug: Daratumumab; Biological: KRAS vaccine; Drug: Nivolumab Sponsors: Georgetown University; Bristol-Myers Squibb; Janssen, LP; Targovax ASA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
